483
Kasia Osadzinska, MDKasia Osadzinska, MD – FDA 483, Jun 15, 2021
Record Details
The FDA inspected Cornerstone Research Institute (Kasia Osadzinska, MD) in Altamonte Springs, FL, regarding a Phase 3 clinical trial (Protocol HTX-011-302). The inspection revealed that the investigation was not conducted in accordance with the investigational plan. Specifically, subjects received rescue medication doses exceeding protocol limits and ineligible subjects were enrolled into the study.
View Company Profile
ID · 29536a33-4ad1-45b3-b416-14ed032ad304
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.